Alper Findikcioglu
Overview
Explore the profile of Alper Findikcioglu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
83
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Onan E, Torun D, Kozanoglu R, Micozkadioglu H, Beyaz S, Ozgozen L, et al.
Ulus Travma Acil Cerrahi Derg
. 2024 Mar;
30(3):174-184.
PMID: 38506381
Background: Crush Syndrome is a major cause of morbidity and mortality following large-scale catastrophic earthquakes. Since there are no randomized controlled studies on Crush Syndrome, knowledge on this subject is...
2.
Yildiz O, Dae S, Findikcioglu A, Kose F
Rev Assoc Med Bras (1992)
. 2021 Nov;
67(7):1015-1020.
PMID: 34817516
Objective: Pulmonary metastasectomy for the treatment of metastatic colorectal cancer is essential, but high ranked evidence of survival benefit is lacking. Here, we aimed to examine the prognostic factors after...
3.
Onal C, Findikcioglu A, Guler O, Reyhan M
Breast
. 2020 Oct;
54:197-202.
PMID: 33125983
Background: To assess the predictive value of F-fluorodeoxyglucose positron-emission tomography (FDG-PET/CT) in detecting mediastinal lymph node metastasis with histopathologic verification in breast cancer (BC) patients. Materials And Methods: Between February...
4.
Topkan E, Selek U, Ozdemir Y, A Besen A, Guler O, Yildirim B, et al.
J Oncol
. 2018 Dec;
2018:4518935.
PMID: 30515211
We aimed to identify the fatal pulmonary hemorrhage- (FPH-) related risk factors in stage 3B/C squamous-cell lung carcinoma (SqCLC) patients treated with definitive concurrent chemoradiotherapy (C-CRT). Medical records of 505...
5.
Topkan E, Selek U, Ozdemir Y, Yildirim B, Guler O, Ciner F, et al.
Int J Radiat Oncol Biol Phys
. 2018 Jun;
101(5):1123-1132.
PMID: 29887509
Purpose: To investigate the incidence and influence of tumor cavitation (TC) on survival outcomes of locally advanced squamous cell lung cancer (LA-SqCLC) patients treated with concurrent chemoradiation therapy (C-CRT). Methods...
6.
Findikcioglu A, Kilic D, Karadayi S, Canpolat T, Reyhan M, Hatipoglu A
Thorac Cancer
. 2017 Sep;
4(1):35-40.
PMID: 28920318
Background: An elastofibroma is a benign, soft-tissue tumor and is important in the differential diagnosis of thoracic wall masses. Here, patients with elastofibromas who underwent thoracic surgery were retrospectively reviewed...
7.
8.
Kilic D, Findikcioglu A, Tepeoglu M, Vural C
Tex Heart Inst J
. 2015 Sep;
42(4):400-2.
PMID: 26413029
Primary chondromyxoid fibroma is a benign bone tumor. Its localization in the sternum is quite rare; we found only 6 relevant reports. We report our diagnosis and treatment of a...
9.
Mertsoylu H, Kose F, Sumbul A, Sedef A, Dogan O, Besen A, et al.
Med Sci Monit
. 2015 Mar;
21:661-6.
PMID: 25731741
Background: Concurrent chemoradiotherapy is the current standard treatment for inoperable stage III non-small cell lung cancer (NSCLC). In this study we aimed to investigate the efficacy and toxicity of CCRT...
10.
Erhamamci S, Reyhan M, Nursal G, Torun N, Yapar A, Findikcioglu A, et al.
Ann Nucl Med
. 2015 Feb;
29(5):420-5.
PMID: 25666569
Objective: Elastofibroma dorsi (ED) is a rare pseudotumor of the soft tissues that can also show 18F-fluorodeoxyglucose ((18)F-FDG) uptake on positron emission tomography combined with computed tomography (PET/CT) imaging. The...